Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-1,742
Closed -$489K 187
2023
Q2
$489K Sell
1,742
-20,899
-92% -$5.44M 0.02% 650
2023
Q1
$5.79M Buy
+22,641
New +$6.6M 0.23% 74
2022
Q4
Sell
-118,266
Closed -$32.8M 1504
2022
Q3
$32.8M Buy
+118,266
New +$33.3M 1.15% 11
2022
Q2
Sell
-27,812
Closed -$6.66M 1679
2022
Q1
$6.66M Buy
27,812
+15,002
+117% +$3.51M 0.25% 102
2021
Q4
$2.94M Buy
+12,810
New +$2.72M 0.11% 185
2021
Q3
Sell
-32,443
Closed -$7.69M 1265
2021
Q2
$7.69M Sell
32,443
-51,869
-62% -$13M 0.18% 162
2021
Q1
$20.4M Sell
84,312
-24,788
-23% -$5.53M 0.63% 34
2020
Q4
$22.7M Buy
109,100
+92,100
+542% +$18.1M 0.75% 32
2020
Q3
$2.88M Buy
+17,000
New +$2.99M 0.38% 50

Other funds holding CI

Ergoteles's CI Position: Q3 2023 in Review

Ergoteles sold out of Cigna (CI) in Q3 2023, closing a stake of 1,742 shares — an estimated $489K sold.

Ergoteles first reported a position in CI in Q3 2020 and held it in 9 quarters. The position peaked at $32.8M in Q3 2022. 1,493 funds tracked by Wall St. Rank hold CI as of Q3 2023.

  • Ergoteles reported no remaining Cigna position as of Q3 2023 after selling out during the quarter.
  • Ergoteles sold 1,742 Cigna shares in Q3 2023, an estimated $489K.
  • Ergoteles first reported a position in Cigna in Q3 2020 and held it in 9 quarters.
  • Ergoteles's Cigna position peaked at $32.8M in Q3 2022.
  • 1,493 funds tracked by Wall St. Rank held Cigna as of Q3 2023.

Based on Ergoteles's 13F filing for Q3 2023, filed 14 Nov 2023.